Which HEDIS measure assesses the use of beta-blockers after a heart attack?

The measure that specifically assesses the use of beta-blockers after a heart attack is the Beta-Blocker Therapy for Patients with Heart Attack measure. This measure evaluates the percentage of adult patients who were discharged from the hospital following a heart attack (myocardial infarction) and who received a prescription for beta-blockers to be taken post-discharge.

Beta-blockers play a crucial role in the management of patients with a history of myocardial infarction as they help to improve outcomes by reducing the risk of subsequent cardiovascular events. Therefore, this measure is important for monitoring the adherence to this guideline and ensuring that patients receive necessary therapy to optimize their recovery and reduce the likelihood of complications.

The other measures mentioned, while related to cardiac care, assess different aspects of treatment and management. The Cardiac Rehabilitation measure focuses on participation in rehabilitation programs, the Coronary Artery Disease measure assesses the management of patients with ongoing coronary artery disease, and the Heart Failure Management measure pertains to the treatment of patients with heart failure. Each measure serves its purpose, but it is the Beta-Blocker Therapy measure that directly evaluates the administration of beta-blockers specifically after a heart attack.